Acute biphenotypic leukemia

From WikiMD.org
Jump to navigation Jump to search

Acute Biphenotypic Leukemia

Acute Biphenotypic Leukemia (pronunciation: a-kyoot by-fen-o-typ-ik loo-kee-mee-uh), also known as Mixed Phenotype Acute Leukemia (MPAL), is a rare type of leukemia that does not fit well into the standard classification of leukemia. The term "biphenotypic" refers to the presence of two different types of cells, myeloid and lymphoid, in the same individual.

Etymology

The term "Acute Biphenotypic Leukemia" is derived from the Greek words "akutos" (meaning sharp or severe), "bi" (meaning two), "phenos" (meaning show or appear) and "leukos" (meaning white) and "haima" (meaning blood).

Diagnosis

Diagnosis of Acute Biphenotypic Leukemia is based on the identification of both myeloid and lymphoid cells in the blood or bone marrow. This is typically done through a bone marrow biopsy and cytogenetic analysis.

Treatment

Treatment for Acute Biphenotypic Leukemia typically involves chemotherapy, and may also include stem cell transplantation.

Prognosis

The prognosis for Acute Biphenotypic Leukemia varies depending on a number of factors, including the patient's age, overall health, and the specific characteristics of the leukemia cells.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski